Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Therapeutic Stents Market by Type (Coronary Stents, Peripheral Stents, Stent Related Implants) and by Material (Metallic Biomaterials, Polymers Biomaterials, Natural Biomaterials): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03710

Pages: NA

Charts: NA

Tables: NA

Therapeutic stent is a metallic or a polymer tube implanted into the lumen of blood vessels or ducts to keep the passage open. A stent implant is commonly used for the treatment of cardiac abnormalities such as blocked blood vessels. In addition, stents are implanted in the esophagus to facilitate the passage of food & beverages in patients suffering from esophageal cancer.

The global therapeutic stents market is expected to witness rapid growth due to rise in geriatric population (majorly of the people highly susceptible to strokes and require stent implant for treatment), technological advancements in stents, increased adoption rate of these devices, and increased risk of restenosis in patients undergoing angioplasty. In addition, unhealthy diet habits and lack of necessary physical activity lead to the development of cardiovascular diseases, which increase the need for percutaneous coronary interventions. Conversely, high specificity of stents, exorbitant cost of stent implant procedures, and stringent government regulations are the key factors that hamper the market growth.

The report segments the global therapeutic stents market based on product, material, and region. Based on product, the market is divided into coronary stents (drug-eluting stents, bare metal stents, and bioabsorbable stents), peripheral stents, and stent related implants. Based on material, the market is classified into metallic biomaterials, polymer biomaterials, and natural biomaterials. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA regions.

The key players operating in the therapeutic stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS SA, and Terumo Corporation.

Key Benefits

  • The report provides an in-depth analysis of market trends, macro-economic indicators, and governing factors.
  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the market that helps identify the upcoming market opportunities.
  • Recent industry trends and developments and the future opportunities are also covered.
  • Extensive knowledge about the key market players and their strategies is provided.
  • Comprehensive analysis of the various factors that drive and restrain the growth of the market is provided.

 Key Market Segments

  • By Type
    • Coronary Stents
      • Drug Eluting Stents DES
      • Bare Metal Coronary Stents
      • Bioabsorbable Stent
    • Peripheral Stents
      • Iliac
      • Femoral Popliteal
      • Renal
      • Carotid
    • Stent Related Implants
      • Synthetic Grafts
      • Vena Cava Filters
  • By Material
    • Metallic Biomaterials
    • Polymers Biomaterials
    • Natural Biomaterials
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Biotronik SE and Co. KG
  • Abbott Laboratories
  • STENTYS SA
  • Terumo Corporation.
  • Microport Scientific Corporation
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Medtronic plc
  • B. Braun Melsungen AG
  • C.R. Bard, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: THERAPEUTIC STENTS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Coronary Stents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Drug Eluting Stents DES

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Bare Metal Coronary Stents

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Bioabsorbable Stent

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Peripheral Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Iliac

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Femoral Popliteal

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Renal

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Carotid

        • 4.3.4.1. Market Size and Forecast

    • 4.4. Stent Related Implants

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Synthetic Grafts

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Vena Cava Filters

        • 4.4.4.1. Market Size and Forecast

  • CHAPTER 5: THERAPEUTIC STENTS MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Metallic Biomaterials

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Polymers Biomaterials

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Natural Biomaterials

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: THERAPEUTIC STENTS MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Material

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Therapeutic Stents Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Material

      • 6.2.6. Canada Therapeutic Stents Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Material

      • 6.2.7. Mexico Therapeutic Stents Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Material

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Material

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Therapeutic Stents Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Material

      • 6.3.6. Germany Therapeutic Stents Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Material

      • 6.3.7. Italy Therapeutic Stents Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Material

      • 6.3.8. Spain Therapeutic Stents Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Material

      • 6.3.9. UK Therapeutic Stents Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Material

      • 6.3.10. Russia Therapeutic Stents Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Material

      • 6.3.11. Rest Of Europe Therapeutic Stents Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Material

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Material

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Therapeutic Stents Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Material

      • 6.4.6. Japan Therapeutic Stents Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Material

      • 6.4.7. India Therapeutic Stents Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Material

      • 6.4.8. South Korea Therapeutic Stents Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Material

      • 6.4.9. Australia Therapeutic Stents Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Material

      • 6.4.10. Thailand Therapeutic Stents Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Material

      • 6.4.11. Malaysia Therapeutic Stents Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Material

      • 6.4.12. Indonesia Therapeutic Stents Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Material

      • 6.4.13. Rest of Asia Pacific Therapeutic Stents Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Material

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Material

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Therapeutic Stents Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Material

      • 6.5.6. South Africa Therapeutic Stents Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Material

      • 6.5.7. Saudi Arabia Therapeutic Stents Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Material

      • 6.5.8. UAE Therapeutic Stents Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Material

      • 6.5.9. Argentina Therapeutic Stents Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Material

      • 6.5.10. Rest of LAMEA Therapeutic Stents Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Material

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott Laboratories

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. B. Braun Melsungen AG

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Biotronik SE And Co. KG

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Boston Scientific Corporation

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. C.R. Bard, Inc.

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Elixir Medical Corporation

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Medtronic Plc

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Microport Scientific Corporation

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. STENTYS SA

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Terumo Corporation.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC STENTS MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL THERAPEUTIC STENTS MARKET FOR CORONARY STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL THERAPEUTIC STENTS MARKET FOR PERIPHERAL STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC STENTS MARKET FOR STENT RELATED IMPLANTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC STENTS MARKET, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC STENTS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC STENTS MARKET FOR POLYMERS BIOMATERIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC STENTS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC STENTS MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA THERAPEUTIC STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 13. U.S. THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 14. U.S. THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 15. CANADA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 16. CANADA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE THERAPEUTIC STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 26. ITALY THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 27. ITALY THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 30. UK THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 31. UK THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC THERAPEUTIC STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 39. CHINA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CHINA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 43. INDIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 44. INDIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA THERAPEUTIC STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 66. UAE THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 67. UAE THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA THERAPEUTIC STENTS, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA THERAPEUTIC STENTS, BY MATERIAL, 2025-2033 ($MILLION)
  • TABLE 72. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 73. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 74. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 75. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 76. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 78. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 79. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 80. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 81. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
  • TABLE 83. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
  • TABLE 84. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
  • TABLE 85. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 86. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 88. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 89. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 90. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. C.R. BARD, INC.: KEY EXECUTIVES
  • TABLE 93. C.R. BARD, INC.: COMPANY SNAPSHOT
  • TABLE 94. C.R. BARD, INC.: OPERATING SEGMENTS
  • TABLE 95. C.R. BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 96. C.R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. ELIXIR MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 98. ELIXIR MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 99. ELIXIR MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 100. ELIXIR MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 101. ELIXIR MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 103. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 104. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 105. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 106. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 108. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 109. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 110. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. STENTYS SA: KEY EXECUTIVES
  • TABLE 113. STENTYS SA: COMPANY SNAPSHOT
  • TABLE 114. STENTYS SA: OPERATING SEGMENTS
  • TABLE 115. STENTYS SA: PRODUCT PORTFOLIO
  • TABLE 116. STENTYS SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. TERUMO CORPORATION.: KEY EXECUTIVES
  • TABLE 118. TERUMO CORPORATION.: COMPANY SNAPSHOT
  • TABLE 119. TERUMO CORPORATION.: OPERATING SEGMENTS
  • TABLE 120. TERUMO CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 121. TERUMO CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC STENTS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL THERAPEUTIC STENTS MARKET
  • FIGURE 3. SEGMENTATION THERAPEUTIC STENTS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN THERAPEUTIC STENTS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALTHERAPEUTIC STENTS MARKET
  • FIGURE 11. THERAPEUTIC STENTS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. THERAPEUTIC STENTS MARKET FOR CORONARY STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. THERAPEUTIC STENTS MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. THERAPEUTIC STENTS MARKET FOR STENT RELATED IMPLANTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. THERAPEUTIC STENTS MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 16. THERAPEUTIC STENTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. THERAPEUTIC STENTS MARKET FOR POLYMERS BIOMATERIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. THERAPEUTIC STENTS MARKET FOR NATURAL BIOMATERIALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: THERAPEUTIC STENTS MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. BIOTRONIK SE AND CO. KG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. C.R. BARD, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. C.R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. C.R. BARD, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. ELIXIR MEDICAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. ELIXIR MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. ELIXIR MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. STENTYS SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. STENTYS SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. STENTYS SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. TERUMO CORPORATION.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. TERUMO CORPORATION.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. TERUMO CORPORATION.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Therapeutic Stents Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved